Opportunities in automation, biopharmaceutical production expansion, and regional investment shifts drive demand for advanced equipment, real-time analytics, and sustainable solutions. Pharmaceutical ...

Specialized expertise in biologics, automation, strategic partnerships, and robust risk management drive growth and ...

AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.

Asahi Kasei acquires Aicuris for €780M ($920M), adding anti-infective assets to its transplant and nephrology specialty pharmaceutical platform.

DARPA's EQUIP-A-Pharma program will leverage a customized chemical synthesis platform and Aprecia's 3D printing technology to demonstrate agile manufacturing applications for delivering safe and ...

Continuous pharmaceutical manufacturing represents a significant shift from traditional batch processing, integrating continuous flow methods, advanced process analytical technology (PAT) and ...

For decades, Africa has consumed medicines it did not manufacture. Across much of the continent, between 70 and 90 percent of ...

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D printing and proprietary delivery systems, today announced a strategic ...

Granulation is a critical unit operation in pharmaceutical manufacturing, where fine powders are agglomerated into granules to improve flow properties, uniformity, and compaction performance. The ...

What is Real-Time Release Testing? Real-Time Release Testing (RTRT) is an advanced approach to biopharmaceutical manufacturing quality control that improves upon current systems. RTRT is defined as ...